Form 4 for IMCR Immunocore Holdings plc
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001415889-24-005720 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-28 | 2024-02-26+ | IMCR | Berman David M | HEAD OF R, D | M - OptEx | $17.46 | +83.5K | 28.6K | New | +$1.46M |
| DM | 2024-02-28 | 2024-02-26+ | IMCR | Berman David M | HEAD OF R, D | S - Sale+OE | $70.79 | -83.5K | 50.5K | -62% | -$5.91M |
| DM | 2024-02-28 | 2024-02-26+ | IMCR | Berman David M | HEAD OF R, D | M - OptEx | $0.00 | -83.5K | 363.2K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-02-27 | M | A | 54,938 | $17.46 | 54,938 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-02-27 | S | D | 21,152 | $70.42 | 29,338 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.835 to $70.8248 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Ordinary Shares | 2024-02-27 | S | D | 25,944 | $71.32 | 3,394 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.84 to $71.8307 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Ordinary Shares | 2024-02-27 | S | D | 3,394 | $71.97 | 0 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.85 to $72.28 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Ordinary Shares | 2024-02-26 | S | D | 2,037 | $71.31 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.09 to $71.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Ordinary Shares | 2024-02-26 | S | D | 26,516 | $70.60 | 2,037 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.09 to $71.088 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Ordinary Shares | 2024-02-26 | M | A | 28,553 | $17.46 | 28,553 | D | — | — | |
| 8 | Common | Ordinary Shares | 2024-02-27 | S | D | 4,448 | $69.45 | 50,490 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.835 to $69.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Derivative | Employee Share Option (Right to Buy) | 2024-02-27 | M | D | 54,938 | $0.00 | 308,299 | D | $17.46 · — to 2028-09-12 | 54,938 Ordinary Shares | (F8) Immediately exercisable. |
| 10 | Derivative | Employee Share Option (Right to Buy) | 2024-02-26 | M | D | 28,553 | $0.00 | 363,237 | D | $17.46 · — to 2028-09-12 | 28,553 Ordinary Shares | (F8) Immediately exercisable. |